Smoking Cessation Treatment among Patients in Community-Based Substance Abuse Rehabilitation Programs: Exploring Predictors of Outcome as Clues Toward Treatment Improvement

REFERENCES

• Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, May 2008. Treating Tobacco and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service, 2008.
   Google Scholar
• Fiore MC, Smith SS, Jorenby D, Baker T. The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. JAMA 1994; 271:1940–1947.
   PubMed Web of Science ®Google Scholar
• Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB. A controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340:685–691.
   PubMed Web of Science ®Google Scholar
• Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR, Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA 2006; 296:56–63.
   PubMed Web of Science ®Google Scholar
• Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KE. Varenicline, an alph 4 beta 2 nictone acetylcholine receptor partial agonist, vs sustained release bupropion and placebo for smoking cessation. JAMA 2006; 296:47–55.
   PubMed Web of Science ®Google Scholar
• Rose JE, Levin ED, Behm FM, Adivi C, Schur C. Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther 1990; 47:323–330.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Higgins ST, Hughes JR, Bickel WK. Nicotine and caffeine use in cocaine-dependent individuals. J Subst Abuse 1993; 5:117–130.
   PubMedGoogle Scholar
• Kalman D, Morissete SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005; 14:106–123.
   PubMed Web of Science ®Google Scholar
• Reid MS, Fallon B, Sonne S, Nunes N, Lima J, Tyson C, Hiott R, Arfken C, Bohs R, Orr D, Muir J, Pihlgren E, Loree E, Fuller B, Giordano L, Robinson J, Rotrosen J. Implementation of smoking cessation treatment at substance abuse rehabilitation programs: Smoking behavior and treatment feasibility across varied community based outpatient programs. J Addict Med 2007; 1:154–160.
   PubMed Web of Science ®Google Scholar
• Stark MJ, Campbell BK. Drug use and cigarette smoking in applicants for drug abuse treatment. J Subst Abuse 1993; 5:175–181.
   PubMedGoogle Scholar
• Tonneatto A, Sobell L, Sobell MB, Kozlowski LT. Effect of cigarette smoking on alcohol treatment outcome. J Subst Abuse 1995; 7:245–252.
   PubMedGoogle Scholar
• Burling TA, Ziff DC. Tobacco smoking: A comparison between alcohol and drug abuse inpatients. Addict Behav 1985; 13:185–190.
   Web of Science ®Google Scholar
• Keenan RM, Hatsukami DK, Pickens RW, Gust SW, Strelow LJ. The relationship between chronic ethanol exposure and cigarette smoking in the laboratory and the natural environment. Psychopharmacology 1990; 100:77–83.
   PubMed Web of Science ®Google Scholar
• York JL, Hirsch JA. Drinking patterns and health status in smoking and nonsmoking alcoholics. Alcohol Clin Exp Res 1995; 19:666–673.
   PubMed Web of Science ®Google Scholar
• Hughes JR. Treatment of smoking cessation in smokers with past alcohol/drug problems. J Subst Abuse Treat 1993; 10:181–187.
   PubMed Web of Science ®Google Scholar
• Kreek MJ. Multiple drug use patterns and their consequences. In Psychopharmacology: The Third Generation of Progress. Meltzer MY, ed. New York, NY: Raven Press, 1987; 1597–1604.
   Google Scholar
• Hurt RD, Offord KP, Crogan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton J, III. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA 1996; 275:1097–1103.
   PubMed Web of Science ®Google Scholar
• Joseph AM. Nicotine treatment at the Drug Dependency Program of the Minneapolis VA Medical Center: A researcher’s perspective. J Subst Abuse Treat 1993; 10:147–152.
   PubMed Web of Science ®Google Scholar
• Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence. J Stud Alcohol 2004; 65:681–691.
   PubMed Web of Science ®Google Scholar
• Burling TA, Marshall GD, Seidner AL. Smoking cessation for substance abuse inpatients. J Subst Abuse 1991; 3:269–276.
   PubMedGoogle Scholar
• Burling TA, Burling AS, Latini D. A controlled smoking cessation trial for substance-dependent patients. J Consult Clin Psychol 2001; 69:295–304.
   PubMed Web of Science ®Google Scholar
• Hurt RD, Eberman KM, Croghan IT, Offord KP, Davis LJ, Morse RM, Palmen MA, Bruce BK. Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial. Alcohol Clin Exp Res 1994; 18:867–872.
   PubMed Web of Science ®Google Scholar
• Hays JT, Schroeder DR, Offord KP, Croghan IT, Patten CA, Hurt RD, Jorenby DE, Fiore MC. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med 1999; 21:244–250.
   PubMed Web of Science ®Google Scholar
• Campbell BK, Wander N, Stark MJ, Holbert T. Treating cigarette smoking in drug-abusing clients. J Subst Abuse Treat 1995; 12:89–94.
   PubMed Web of Science ®Google Scholar
• Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 2004; 72:1144–1156.
   PubMed Web of Science ®Google Scholar
• Reid MS, Fallon B, Flammino F, Sonne S, Nunes N, Kourniotis E, Brady R, Burgess C, Arfken C, Pihlgren E, Giordano L, Starosta A, Robinson J, Rotrosen J. Smoking cessation treatment at community based substance abuse rehabilitation programs. J Subst Abuse Treat 2008; 35:68–77.
   PubMed Web of Science ®Google Scholar
• Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, Rawson RA, Ling W. Smoking cessation in methadone maintenance. Addiction 2002; 97:1217–1228, discussion 1325.
   Web of Science ®Google Scholar
• Saxon AJ, McGuffin R, Walker RD. An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol- and drug-dependent inpatients. J Subst Abuse Treat 1997; 14:333–337.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry 2005; 162(8):1452–1460.
   PubMed Web of Science ®Google Scholar
• Heatherton T, Kozlowski L, Freckler R, Fagerstrom K. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86:1119–1127.
   PubMedGoogle Scholar
• Frosch DL, Shoptaw S, Jarvik ME, Rawson RA, Ling W. Interest in smoking cessation among methadone maintained outpatients. J Addict Dis 1998; 17:9–19.
   PubMed Web of Science ®Google Scholar
• Curry SJ, Grothaus L, McBride C. Reasons for quitting: Intrinsic and extrinsic motivation for smoking cessation in a population-based sample of smokers. Addict Behav 1997; 22:727–739.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O’Brien CP. New data from the Addiction Severity Index: Reliability and validity in three centers. J Nerv Ment Dis 1985; 173:412–423.
   PubMed Web of Science ®Google Scholar
• Sonne SC, Nunes EV, Jiang H, Tyson C, Rotrosen J, Reid MS. The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. Am J Addict 2010; 19(2):111–118.
   PubMed Web of Science ®Google Scholar
• Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal: A replication and extension. Arch Gen Psychiatry 1991; 48:52–59.
   PubMed Web of Science ®Google Scholar
• Mezinskis J, Dyrenforth S, Goldsmith RJ, Somoza E. Craving and withdrawal symptoms for various drugs of abuse. Psychiatr Ann 1998; 28:577–583.
   Web of Science ®Google Scholar
• SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4:149–159.
   PubMedGoogle Scholar
• Frosch DL, Nahom D, Shoptaw S. Optimizing smoking cessation outcomes among the methadone maintained. J Subst Abuse Treat 2002; 23:425–430.
   PubMed Web of Science ®Google Scholar
• Hurt RD, Wolter TD, Rigotti N, Hays JT, Niaura R, Durcan MJ, Gonzales D, Sachs DP, Johnston JA, Offord KP. Bupropion for pharmacologic relapse prevention to smoking: Predictors of outcome. Addict Behav 2002; 27:493–507.
   PubMed Web of Science ®Google Scholar
• Harris KJ, Okutemi KS, Catley D, Mayo MS, Ge B, Ahluwalia JS. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med 2004; 38:498–502.
   PubMed Web of Science ®Google Scholar
• Piper ME, Cook JW, Schlam TR, Jorenby DE, Smith SS, Bolt DM, Loh WY. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res 2010; 12(6):647–657.
   PubMed Web of Science ®Google Scholar
• Bobo JK, Lando HA, Walker RD, McIlvain HE. Predictors of tobacco quit attempts among recovering alcoholics. J Subst Abuse 1996; 8:431–433.
   PubMedGoogle Scholar
• Shoptaw S, Jarvik ME, Ling W, Rawson RA. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav 1996; 21:409–412.
   PubMed Web of Science ®Google Scholar
• Martin RA, Rohsenow DJ, MacKinnon SV, Abrams DB, Monti PM. Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend 2006; 83:73–78.
   PubMed Web of Science ®Google Scholar
• Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989; 1:7–10.
   PubMed Web of Science ®Google Scholar
• Frosch DL, Shoptaw S, Nahom D, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone maintained opiate dependent individuals. Exp Clin Psychopharmacol 2000; 8:97–103.
   PubMed Web of Science ®Google Scholar
• Bobo JK, Gilchrist LD, Schilling RF, Noach B, Schinke SP. Cigarette smoking cessation attempts by recovering alcoholics. Addict Behav 1987; 12:209–215.
   PubMed Web of Science ®Google Scholar
• Chait LD, Griffiths RR. Effects of methadone on human cigarette smoking and subjective ratings. J Pharmacol Exp Ther 1984; 229:636–640.
   PubMed Web of Science ®Google Scholar
• Richter KP, Hamilton AK, Hall S, Catley D, Cox LS, Grobe J. Patterns of smoking and methadone dose in drug treatment patients. Exp Clin Psychopharmacol 2007; 15:144–153.
   PubMed Web of Science ®Google Scholar
• Story J, Stark MJ. Treating cigarette smoking in methadone maintenance clients. J Psychoactive Drugs 1991; 23:203–215.
   PubMed Web of Science ®Google Scholar